VR Adviser, LLC

报告期 2026-03-31 · CIK 0001615982

持仓数

前50大市值合计

$2.68B

报告期

2026-03-31

当前持仓调仓

组合演变前 6 大持仓 + 其他逐季市值($B) · 点图或下方季度看该季调仓

看某季调仓:

26Q1 25Q4 25Q3 25Q2 25Q1 24Q4 24Q3 24Q2 24Q1 23Q4 23Q3 23Q2 23Q1 22Q4 22Q3 22Q2

23Q2 调仓2023-03-31 → 2023-06-30 · 共 24 项建仓 10增持 5减持 4清仓 5

方向

标的

Δ市值

现股数(环比)

建仓

FDMT 4D MOLECULAR THERAPEUTICS IN

+$54.2M

3,000,000

减持

PLRX PLIANT THERAPEUTICS INC

-$32.8M

288,949 -80%

建仓

DYN DYNE THERAPEUTICS INC

+$24.5M

2,173,913

调仓由相邻两季 13F 持仓相减推导(非逐笔成交);方向按股数增减,Δ市值受股价波动影响、符号可与方向相反;13F 申报滞后最长 45 天。

— DICE THERAPEUTICS INC

增持

— MERUS N V

+$22.9M

1,726,214 +41%

建仓

— PHARVARIS N V

+$20.1M

1,326,200

建仓

RYTM RHYTHM PHARMACEUTICALS INC

+$18.0M

1,090,000

减持

— TERNS PHARMACEUTICALS INC

-$16.8M

2,972,869 -18%

清仓

— AEROVATE THERAPEUTICS INC

-$16.8M

0 -100%

建仓

ORIC ORIC PHARMACEUTICALS INC

+$16.6M

2,142,856

清仓

— VECTIVBIO HLDG AG

-$15.9M

0 -100%

清仓

ANNX ANNEXON INC

-$12.4M

0 -100%

减持

— AMBRX BIOPHARMA INC

+$11.5M

2,484,960 -25%

建仓

— APPLIED THERAPEUTICS INC

+$7.2M

5,658,034

建仓

— ADVERUM BIOTECHNOLOGIES INC

+$6.2M

3,886,246

建仓

— PRAXIS PRECISION MEDICINES I

+$6.1M

5,304,410

增持

VRDN VIRIDIAN THERAPEUTICS INC

+$4.7M

3,082,622 +14%

清仓

FULC FULCRUM THERAPEUTICS INC

-$3.7M

0 -100%

增持

ELVN ENLIVEN THERAPEUTICS INC

-$3.0M

2,230,127 +1%

建仓

— AEGLEA BIOTHERAPEUTICS INC

+$2.9M

6,343,221

减持

COGT COGENT BIOSCIENCES INC

+$2.8M

4,684,132 -4%

增持

TRVI TREVI THERAPEUTICS INC

+$2.5M

3,422,397 +12%

建仓

BDTX BLACK DIAMOND THERAPEUTICS I

+$1.8M

353,629

增持

— AVALO THERAPEUTICS INC

-$1.3M

1,250,000 +25%